Grant: Alliance Grants
University of Toronto
$158,067.00
New mass tags and enhanced sensitivity for mass cytometry reagents
FY 2024-25
Summary
The purpose of this project is to develop better tools to help scientists in the biomedical area study biological samples. Mass cytometry, also know as CyTOF (cytometry by time-of-flight mass spectrometry). is a technology developed in Canada and manufactured by Standard BioTools Canada in Markham ON that enables scientists to measure and quantify many biomarkers simultaneously on cells and tissue samples. Biomarkers are proteins and other biomolecules expressed on the surface of cells or inside the cells. They convey information about cell type, behavior and function as well as the disease state of a cell. CyTOF employs reagents based on antibodies labeled with heavy metal isotopes to detect proteins and other biomarkers expressed on individual cells. In suspension mass cytometry, cells are injected into the plasma torch of an atomic mass spectrometer, where the cells are vaporized, atomized and ionized to generate a cloud of the metal ions that were attached to each cell. In imaging mass cytometry, tissue sections are irradiated pixel-by-pixel with a laser to generate a plume that is then ionized. These ions are then analyzed by mass spectrometry. In this way, one can examine individual cells at high throughput or obtain high resolution images of tissue sections. In current technology, one can measure ~50 biomarkers per cell at 500 cells per second. We propose to create new reagents that will increase this number up to 80 biomarkers per cell. To identify proteins expressed at very low levels, we will create a different set of reagents that will increase signal intensity by 10 to 100 times. This new technology will enhance our ability to study biological and disease processes and may in the future enhance early diagnosis of disease.
Program
Alliance Grants
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
598570-2024
Name nom
Winnik, Mitchell MA
Department département
Chemistry (St. George Campus)
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
158067
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
New mass tags and enhanced sensitivity for mass cytometry reagents
Keywords
bioanalytical chemistry; mass cytometry; mesoporous silica nanoparticles; metal-chelating polymers; minimizing non-specific binding
Application summary
The purpose of this project is to develop better tools to help scientists in the biomedical area study biological samples. Mass cytometry, also know as CyTOF (cytometry by time-of-flight mass spectrometry). is a technology developed in Canada and manufactured by Standard BioTools Canada in Markham ON that enables scientists to measure and quantify many biomarkers simultaneously on cells and tissue samples. Biomarkers are proteins and other biomolecules expressed on the surface of cells or inside the cells. They convey information about cell type, behavior and function as well as the disease state of a cell. CyTOF employs reagents based on antibodies labeled with heavy metal isotopes to detect proteins and other biomarkers expressed on individual cells. In suspension mass cytometry, cells are injected into the plasma torch of an atomic mass spectrometer, where the cells are vaporized, atomized and ionized to generate a cloud of the metal ions that were attached to each cell. In imaging mass cytometry, tissue sections are irradiated pixel-by-pixel with a laser to generate a plume that is then ionized. These ions are then analyzed by mass spectrometry. In this way, one can examine individual cells at high throughput or obtain high resolution images of tissue sections. In current technology, one can measure ~50 biomarkers per cell at 500 cells per second. We propose to create new reagents that will increase this number up to 80 biomarkers per cell. To identify proteins expressed at very low levels, we will create a different set of reagents that will increase signal intensity by 10 to 100 times. This new technology will enhance our ability to study biological and disease processes and may in the future enhance early diagnosis of disease.